Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1)

MLA

Marme, F., et al. Incidence of Germline Mutations in Risk Genes Including BRCA1/2 in Consecutive Ovarian Cancer (OC) Patients (AGO TR-1). 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1223532470&authtype=sso&custid=ns315887.

APA

Marme, F., Harter, P., Hauke, J., Heitz, F., Reuss, A., Kommoss, S., Heimbach, A., Prieske, K., Richters, L., Burges, A., Neidhardt, G., de Gregorio, N., El-Balat, A., Hilpert, F., Meier, W., Heubner, M., Kast, K., Braicu, I., Hahnen, E., & Schmutzler, R. (2016). Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).

Chicago

Marme, F., P. Harter, J. Hauke, F. Heitz, A. Reuss, S. Kommoss, A. Heimbach, et al. 2016. “Incidence of Germline Mutations in Risk Genes Including BRCA1/2 in Consecutive Ovarian Cancer (OC) Patients (AGO TR-1).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1223532470&authtype=sso&custid=ns315887.